BRIEF published on 01/20/2025 at 07:05, 1 year ago INFICON Releases Preliminary Year-End 2024 Results and 2025 Communication Schedule Financial Performance INFICON Market Outlook 2024 Results Communication Schedule
BRIEF published on 01/20/2025 at 07:05, 1 year ago INFICON publie ses résultats préliminaires de fin d'année 2024 et son calendrier de communication pour 2025 Performance Financière INFICON Résultats 2024 Perspectives Du Marché Calendrier Des Communications
BRIEF published on 01/20/2025 at 07:05, 1 year ago Maurel & Prom to Acquire Key Gas Asset in Colombia Infrastructure Development Maurel & Prom Energy Strategy Sinu-9 Acquisition Colombia Gas Market
BRIEF published on 01/20/2025 at 07:05, 1 year ago Maurel & Prom va acquérir un actif gazier clé en Colombie Maurel & Prom Développement Des Infrastructures Stratégie Énergétique Acquisition De Sinu-9 Marché Du Gaz En Colombie
BRIEF published on 01/20/2025 at 06:35, 1 year ago HBM Healthcare Reports Profit Despite Share Price Decline Investment Strategy Share Price Private Companies Profit HBM Healthcare
BRIEF published on 01/20/2025 at 06:35, 1 year ago HBM Healthcare annonce des bénéfices malgré la baisse du cours de l'action Stratégie D'investissement Entreprises Privées Profit Cours De L'action HBM Santé
BRIEF published on 01/20/2025 at 06:35, 1 year ago Schindler Holding Ltd. Announces Board and Leadership Changes Leadership Transition Schindler Board Changes Josef Ming Chairman Paolo Compagna CEO 2025 General Meeting
BRIEF published on 01/20/2025 at 06:35, 1 year ago Schindler Holding Ltd. annonce des changements au sein de son conseil d'administration et de sa direction Transition De Direction Assemblée Générale 2025 Changements Au Sein Du Conseil D'administration De Schindler Josef Ming Président Paolo Compagna PDG
BRIEF published on 01/20/2025 at 06:35, 1 year ago Formycon Secures EU Approval for Biosimilar FYB203 Formycon AG EU Approval Teva Pharmaceuticals Aflibercept Biosimilar FYB203
BRIEF published on 01/20/2025 at 06:35, 1 year ago Formycon obtient l'approbation de l'UE pour le biosimilaire FYB203 Formycon AG Teva Pharmaceuticals Aflibercept Homologation UE Biosimilaire FYB203
Published on 02/12/2026 at 23:25, 6 minutes ago The Caldwell Partners International Announces Results of Vote for Election of Directors
Published on 02/12/2026 at 22:00, 1 hour 31 minutes ago Electrovaya Reports Fiscal Year Q1 2026 Results
Published on 02/12/2026 at 19:18, 4 hours 13 minutes ago Verdera Energy Closes $20 Million Financing and Provides Update to Proposed Qualifying Transaction and Listing on the TSX-V
Published on 02/12/2026 at 19:00, 4 hours 31 minutes ago Nepra Foods Announces USD$487,849 Debt Conversion
Published on 02/12/2026 at 17:00, 6 hours 31 minutes ago Diamcor Provides Update on Discharge of Security and Indebtedness, and Granting of Extension of Time to Hold the 2025 Annual General Meeting
Published on 02/12/2026 at 21:16, 2 hours 15 minutes ago Form 8.3 - The Vanguard Group, Inc.: JTC plc
Published on 02/12/2026 at 21:15, 2 hours 16 minutes ago Form 8.3 - The Vanguard Group, Inc.: Bluefield Solar Income Fund Limited
Published on 02/12/2026 at 21:14, 2 hours 16 minutes ago Form 8.3 - The Vanguard Group, Inc.: Beazley plc
Published on 02/12/2026 at 21:13, 2 hours 17 minutes ago Form 8.3 - The Vanguard Group, Inc.: Spire Healthcare Group plc
Published on 02/12/2026 at 21:13, 2 hours 18 minutes ago Form 8.3 - The Vanguard Group, Inc.: Oxford Biomedica plc
Published on 02/12/2026 at 21:30, 2 hours ago Aéroports de Paris SA - Processus d'homologation tarifaire 2026
Published on 02/12/2026 at 17:45, 5 hours 46 minutes ago MR.BRICOLAGE SA: ENTERING INTO A NEW SYNDICATED CREDIT FACILITY
